Oasmia Pharmaceutical Seeks to Fill Void in Ovarian Cancer Treatment Market Indicated in Recent National Academy of Medicine ...
New York, March 10, 2016 (GLOBE NEWSWIRE) -- Oasmia Pharmaceutical AB (NASDAQ:OASM), a developer of a new generation of drugs within human and veterinary oncology, today commented on a recent report published by the National Academy of Medicine that …